Clinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease (NAFLD) is heralded as the next big global epidemic. Hepatic de novo lipogenesis (DNL), the synthesis of new fatty acids from non-lipid sources, is thought to play a pivotal role in the development of NAFLD. While there is currently no NAFLD-specific therapeutic age...

Descripción completa

Detalles Bibliográficos
Autores principales: Paglialunga, Sabina, Dehn, Clayton A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027077/
https://www.ncbi.nlm.nih.gov/pubmed/27640119
http://dx.doi.org/10.1186/s12944-016-0321-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027077/
https://www.ncbi.nlm.nih.gov/pubmed/27640119
http://dx.doi.org/10.1186/s12944-016-0321-5

Ejemplares similares